The University of Chicago Header Logo

Connection

Rima McLeod to Mice

This is a "connection" page, showing publications Rima McLeod has written about Mice.
Connection Strength

0.749
  1. Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites. Front Cell Infect Microbiol. 2020; 10:203.
    View in: PubMed
    Score: 0.067
  2. Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii. JCI Insight. 2016 09 22; 1(15):e85955.
    View in: PubMed
    Score: 0.052
  3. Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo. Antimicrob Agents Chemother. 2014; 58(3):1789-92.
    View in: PubMed
    Score: 0.043
  4. Salicylanilide inhibitors of Toxoplasma gondii. J Med Chem. 2012 Oct 11; 55(19):8375-91.
    View in: PubMed
    Score: 0.039
  5. Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections. Proc Natl Acad Sci U S A. 2012 Aug 28; 109(35):14182-7.
    View in: PubMed
    Score: 0.039
  6. Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality. Parasitology. 2012 Jan; 139(1):1-13.
    View in: PubMed
    Score: 0.037
  7. Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-? and reduces parasite burden in HLA-B*0702 mice. Hum Immunol. 2012 Jan; 73(1):1-10.
    View in: PubMed
    Score: 0.037
  8. T. gondii RP promoters & knockdown reveal molecular pathways associated with proliferation and cell-cycle arrest. PLoS One. 2010 Nov 22; 5(11):e14057.
    View in: PubMed
    Score: 0.035
  9. Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201. Vaccine. 2011 Jan 17; 29(4):754-62.
    View in: PubMed
    Score: 0.035
  10. Identification and development of novel inhibitors of Toxoplasma gondii enoyl reductase. J Med Chem. 2010 Sep 09; 53(17):6287-300.
    View in: PubMed
    Score: 0.034
  11. Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans. Vaccine. 2010 May 21; 28(23):3977-89.
    View in: PubMed
    Score: 0.033
  12. Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation. 2008 Oct 23; 5:48.
    View in: PubMed
    Score: 0.030
  13. Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo. PLoS Negl Trop Dis. 2008 Mar 05; 2(3):e190.
    View in: PubMed
    Score: 0.029
  14. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo. Antimicrob Agents Chemother. 2005 Aug; 49(8):3463-7.
    View in: PubMed
    Score: 0.024
  15. Delivery of antimicrobials into parasites. Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):14281-6.
    View in: PubMed
    Score: 0.021
  16. In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain. J Immunol. 2002 Jul 15; 169(2):966-73.
    View in: PubMed
    Score: 0.019
  17. Genetic analysis of influences on survival following Toxoplasma gondii infection. Int J Parasitol. 2002 Feb; 32(2):179-85.
    View in: PubMed
    Score: 0.019
  18. Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice. Sci Rep. 2020 10 12; 10(1):16984.
    View in: PubMed
    Score: 0.017
  19. Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii. Int J Parasitol. 2000 Feb; 30(2):149-55.
    View in: PubMed
    Score: 0.016
  20. Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis. Parasite Immunol. 2000 Jan; 22(1):1-5.
    View in: PubMed
    Score: 0.016
  21. HLA-class II genes modify outcome of Toxoplasma gondii infection. Int J Parasitol. 1999 Sep; 29(9):1351-8.
    View in: PubMed
    Score: 0.016
  22. Prevalence and genetic characterization of Toxoplasma gondii in free-range chickens from grocery stores and farms in Maryland, Ohio and Massachusetts, USA. Parasitol Res. 2017 May; 116(5):1591-1595.
    View in: PubMed
    Score: 0.013
  23. Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception. Clin Infect Dis. 1996 Nov; 23(5):1055-60.
    View in: PubMed
    Score: 0.013
  24. Effects of human class I transgenes on Toxoplasma gondii cyst formation. J Immunol. 1994 May 01; 152(9):4537-41.
    View in: PubMed
    Score: 0.011
  25. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii. ChemMedChem. 2013 Jul; 8(7):1138-60.
    View in: PubMed
    Score: 0.010
  26. Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii. Infect Immun. 2012 Dec; 80(12):4298-308.
    View in: PubMed
    Score: 0.010
  27. Identification of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol. 2011 Apr; 97(2):328-37.
    View in: PubMed
    Score: 0.009
  28. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. J Immunol. 1990 Nov 15; 145(10):3438-41.
    View in: PubMed
    Score: 0.009
  29. Immunogenetics of Toxoplasma gondii informs vaccine design. Trends Parasitol. 2010 Nov; 26(11):550-5.
    View in: PubMed
    Score: 0.008
  30. P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J Immunol. 2010 Jun 15; 184(12):7040-6.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.